News | February 19, 2015

Tau PET Tracers Expanding Alzheimer’s and Frontotemporal Dementia Research

New technology allows imaging of amyloid plaques and tau tangles in living people

Alzheimer's, tau PET tracers, positron emission tomography, dementia, research

February 19, 2015 — One of the hottest topics in current Alzheimer’s research is brain scans that visualize tau pathology in living people. With the advent of positron emission tomography (PET) tracers that label neurofibrillary tangles, researchers are now able to "see" and quantify both hallmark pathologies defined by Alois Alzheimer in 1906: amyloid plaques and tau tangles. Tau tracers dominated the agenda when 340 researchers convened in Miami Beach, Florida, recently to debate the current edge in human amyloid imaging.

Previously, researchers could only detect plaques and tangles by examining brain tissue postmortem. PET also enables researchers to track pathology as people age. PET of amyloid plaques has been around for a decade, but tau PET is new.

Data is pouring in as academic and commercial labs test the current front-runner, T807/AV1451. The tracer is being validated in postmortem tissue and, as advertised, proves to bind phosphorylated tau aggregated into paired helical filaments. Researchers were excited to see the tracer bind in brain regions where neuronal metabolism crashes, and that this appears to match up with the symptoms that characterize both Alzheimer’s in its various forms and the frontotemporal dementias.

More work is needed to sort out the tracer’s technical features, but early indications of how A? and tau amyloids deposit as people age are widely considered to be highly promising. The field is getting crowded: New tau tracers debuted at the conference, and more are expected to come out soon.

For more information: www.alzforum.org

Related Content

GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
PET Imaging Offers New Possibilities in Chronic Liver Disease Management

Hepatic 18F-FDG, 18F-FAC, and 18F-DFA accumulation are affected in a mouse model of autoimmune hepatitis. (A) Histochemical and immunohistochemical analyses of liver sections from vehicle- and ConA-treated mice. Scale bars represent 50 microns. Transverse PET/CT images (B) and quantification (C) of vehicle- and ConA-treated mice injected with 18F-FDG, 18F-FAC, and 18FDFA. Livers are outlined in a white dotted line. Quantification represents radiotracer accumulation in the liver normalized to a background organ. Image courtesy of Salas J.R., Chen B.Y., Wong A., et al.

News | PET Imaging | October 24, 2018
While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications....